Literature DB >> 10400714

Species-independent inhibition of abnormal prion protein (PrP) formation by a peptide containing a conserved PrP sequence.

J Chabry1, S A Priola, K Wehrly, J Nishio, J Hope, B Chesebro.   

Abstract

Conversion of the normal protease-sensitive prion protein (PrP) to its abnormal protease-resistant isoform (PrP-res) is a major feature of the pathogenesis associated with transmissible spongiform encephalopathy (TSE) diseases. In previous experiments, PrP conversion was inhibited by a peptide composed of hamster PrP residues 109 to 141, suggesting that this region of the PrP molecule plays a crucial role in the conversion process. In this study, we used PrP-res derived from animals infected with two different mouse scrapie strains and one hamster scrapie strain to investigate the species specificity of these conversion reactions. Conversion of PrP was found to be completely species specific; however, despite having three amino acid differences, peptides corresponding to the hamster and mouse PrP sequences from residues 109 to 141 inhibited both the mouse and hamster PrP conversion systems equally. Furthermore, a peptide corresponding to hamster PrP residues 119 to 136, which was identical in both mouse and hamster PrP, was able to inhibit PrP-res formation in both the mouse and hamster cell-free systems as well as in scrapie-infected mouse neuroblastoma cell cultures. Because the PrP region from 119 to 136 is very conserved in most species, this peptide may have inhibitory effects on PrP conversion in a wide variety of TSE diseases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10400714      PMCID: PMC112701     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Evidence that the transmission of one source of scrapie agent to hamsters involves separation of agent strains from a mixture.

Authors:  R H Kimberlin; C A Walker
Journal:  J Gen Virol       Date:  1978-06       Impact factor: 3.891

2.  Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins.

Authors:  R J Kascsak; R Rubenstein; P A Merz; M Tonna-DeMasi; R Fersko; R I Carp; H M Wisniewski; H Diringer
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

3.  Isolation of a cDNA clone encoding the leader peptide of prion protein and expression of the homologous gene in various tissues.

Authors:  N K Robakis; P R Sawh; G C Wolfe; R Rubenstein; R I Carp; M A Innis
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

4.  Scrapie susceptibility-linked polymorphisms modulate the in vitro conversion of sheep prion protein to protease-resistant forms.

Authors:  A Bossers; G J Raymond; B Caughey; R de Vries; M A Smits
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

5.  Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease.

Authors:  M S Palmer; A J Dryden; J T Hughes; J Collinge
Journal:  Nature       Date:  1991-07-25       Impact factor: 49.962

Review 6.  Protease-resistant PrP accumulation and scrapie agent replication: a role for sulphated glycosaminoglycans?

Authors:  B Caughey
Journal:  Biochem Soc Trans       Date:  1994-02       Impact factor: 5.407

7.  The genomic identity of different strains of mouse scrapie is expressed in hamsters and preserved on reisolation in mice.

Authors:  R H Kimberlin; C A Walker; H Fraser
Journal:  J Gen Virol       Date:  1989-08       Impact factor: 3.891

8.  Molecular cloning and complete sequence of prion protein cDNA from mouse brain infected with the scrapie agent.

Authors:  C Locht; B Chesebro; R Race; J M Keith
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

9.  Normal host prion protein necessary for scrapie-induced neurotoxicity.

Authors:  S Brandner; S Isenmann; A Raeber; M Fischer; A Sailer; Y Kobayashi; S Marino; C Weissmann; A Aguzzi
Journal:  Nature       Date:  1996-01-25       Impact factor: 49.962

10.  A single hamster PrP amino acid blocks conversion to protease-resistant PrP in scrapie-infected mouse neuroblastoma cells.

Authors:  S A Priola; B Chesebro
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

View more
  17 in total

1.  From conversion to aggregation: protofibril formation of the prion protein.

Authors:  Mari L DeMarco; Valerie Daggett
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

2.  Design and Optimization of Anti-amyloid Domain Antibodies Specific for β-Amyloid and Islet Amyloid Polypeptide.

Authors:  Christine C Lee; Mark C Julian; Kathryn E Tiller; Fanling Meng; Sarah E DuConge; Rehana Akter; Daniel P Raleigh; Peter M Tessier
Journal:  J Biol Chem       Date:  2015-11-24       Impact factor: 5.157

3.  Evidence of a molecular barrier limiting susceptibility of humans, cattle and sheep to chronic wasting disease.

Authors:  G J Raymond; A Bossers; L D Raymond; K I O'Rourke; L E McHolland; P K Bryant; M W Miller; E S Williams; M Smits; B Caughey
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

4.  Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc.

Authors:  Gianluca Moroncini; Nnennaya Kanu; Laura Solforosi; Gil Abalos; Glenn C Telling; Mark Head; James Ironside; Jeremy P Brockes; Dennis R Burton; R Anthony Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-06       Impact factor: 11.205

5.  Inoculation of scrapie with the self-assembling RADA-peptide disrupts prion accumulation and extends hamster survival.

Authors:  Robert Hnasko; Cathrin E Bruederle
Journal:  PLoS One       Date:  2009-02-12       Impact factor: 3.240

Review 6.  Aptamers against prion proteins and prions.

Authors:  Sabine Gilch; Hermann M Schätzl
Journal:  Cell Mol Life Sci       Date:  2009-04-25       Impact factor: 9.261

7.  PrP(C) association with lipid rafts in the early secretory pathway stabilizes its cellular conformation.

Authors:  Daniela Sarnataro; Vincenza Campana; Simona Paladino; Mariano Stornaiuolo; Lucio Nitsch; Chiara Zurzolo
Journal:  Mol Biol Cell       Date:  2004-06-30       Impact factor: 4.138

8.  Cholesterol secosterol adduction inhibits the misfolding of a mutant prion protein fragment that induces neurodegeneration.

Authors:  Johanna C Scheinost; Daniel P Witter; Grant E Boldt; John Offer; Paul Wentworth
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

Review 9.  Recent advances in prion chemotherapeutics.

Authors:  Valerie L Sim; Byron Caughey
Journal:  Infect Disord Drug Targets       Date:  2009-02

10.  Prion protein self-peptides modulate prion interactions and conversion.

Authors:  Alan Rigter; Jan Priem; Drophatie Timmers-Parohi; Jan P M Langeveld; Fred G van Zijderveld; Alex Bossers
Journal:  BMC Biochem       Date:  2009-11-30       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.